'Eli Lilly has stopped the trial of a drug intended for Alzheimer's patients because it made their condition worse, not to mention causing skin cancer. The question that needs to be asked is how and why Lilly pushed a drug through both first and second stage trials, only to find that it makes the targeted condition worse when tested on real human beings in a stage three trial. Obviously, something significant is being missed by modern medicine's approach.'
Read more...
Related Post:
Widget by [ Iptek-4u ]
